TMDX Q1 2022 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$5B

Q1 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$16M+125.2% YoY

Gross Profit

$12M76.2% margin

Operating Income

-$9M-59.0% margin

Net Income

-$11M-66.5% margin

EPS (Diluted)

$-0.38

QoQ Revenue Growth

+64.3%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$20M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$124M

Total Liabilities

$64M

Stockholders' Equity

$60M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16M	$7M	+125.2%
Gross Profit	$12M	$5M	+151.6%
Operating Income	-$9M	-$7M	-44.0%
Net Income	-$11M	-$8M	-33.4%

Revenue Segments

Ocs Liver Product

$8M50%

Ocs Heart Product

$6M36%

Ocs Lung Product

$2M14%

Geographic Segments

UNITED STATES

$14M85%

Non Us And Uk

$2M15%